Minimal contribution of desmethyl-gefitinib, the major human plasma metabolite of gefitinib, to epidermal growth factor receptor (EGFR)-mediated tumour growth inhibition.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples